Bonesupport Q3: Initial take – the profitable growth journey begins - Redeye

Redeye provides its initial comment on BONESUPPORT’s Q3 report. Sales came in c6% above our forecast, and we emphasise that the positive EBIT margin is here to stay. A positive operating cash flow was also achieved, and we dare to say that BONESUPPORT has now begun its profitable growth journey. We anticipate a positive share price reaction of 5-7% during the day.

Länk till analysen i sin helhet: https://www.redeye.se/research/950674/bonesupport-q3-initial-take-the-profitable-growth-journey-begins?utm_source=finwire&utm_medium=RSS